Key points are not available for this paper at this time.
Comparison of midazolam and ketamine efficacies as first-line continuous infusions (CIs) for the treatment of status epilepticus (SE) in children with (CHD).
Javadian et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: